Introduced:
Sep 10, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
2
Actions
1
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Sep 10, 2025
Read twice and referred to the Committee on Finance.
Actions (2)
Read twice and referred to the Committee on Finance.
Type: IntroReferral
| Source: Senate
Sep 10, 2025
Introduced in Senate
Type: IntroReferral
| Source: Library of Congress
| Code: 10000
Sep 10, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (1)
(D-MD)
Sep 10, 2025
Sep 10, 2025
Full Bill Text
Length: 15,561 characters
Version: Introduced in Senate
Version Date: Sep 10, 2025
Last Updated: Nov 15, 2025 2:23 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 2756 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. 2756
To amend title XXVII of the Public Health Service Act, the Internal
Revenue Code of 1986, and the Employee Retirement Income Security Act
of 1974 to reduce patient cost-sharing for prescription drug inhaler
products used to treat breathing disorders such as asthma and chronic
obstructive pulmonary disease, and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
September 10, 2025
Ms. Alsobrooks (for herself and Mr. Van Hollen) introduced the
following bill; which was read twice and referred to the Committee on
Finance
_______________________________________________________________________
A BILL
To amend title XXVII of the Public Health Service Act, the Internal
Revenue Code of 1986, and the Employee Retirement Income Security Act
of 1974 to reduce patient cost-sharing for prescription drug inhaler
products used to treat breathing disorders such as asthma and chronic
obstructive pulmonary disease, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[S. 2756 Introduced in Senate
(IS) ]
<DOC>
119th CONGRESS
1st Session
S. 2756
To amend title XXVII of the Public Health Service Act, the Internal
Revenue Code of 1986, and the Employee Retirement Income Security Act
of 1974 to reduce patient cost-sharing for prescription drug inhaler
products used to treat breathing disorders such as asthma and chronic
obstructive pulmonary disease, and for other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
September 10, 2025
Ms. Alsobrooks (for herself and Mr. Van Hollen) introduced the
following bill; which was read twice and referred to the Committee on
Finance
_______________________________________________________________________
A BILL
To amend title XXVII of the Public Health Service Act, the Internal
Revenue Code of 1986, and the Employee Retirement Income Security Act
of 1974 to reduce patient cost-sharing for prescription drug inhaler
products used to treat breathing disorders such as asthma and chronic
obstructive pulmonary disease, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Affordable Inhalers and Nebulizers
Act of 2025''.
SEC. 2.
PRODUCTS USED TO TREAT BREATHING DISORDERS SUCH AS ASTHMA
AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
(a) Coverage and Cost-Sharing Requirements.--
(1) Private insurance.--
(A) PHSA.--Part D of title XXVII of the Public
Health Service Act (42 U.S.C. 300gg-111 et seq.) is
amended by adding at the end the following new section:
``
AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
(a) Coverage and Cost-Sharing Requirements.--
(1) Private insurance.--
(A) PHSA.--Part D of title XXVII of the Public
Health Service Act (42 U.S.C. 300gg-111 et seq.) is
amended by adding at the end the following new section:
``
SEC. 2799A-11.
INHALER PRODUCTS.
``
(a) In General.--A group health plan, and a health insurance
issuer offering group or individual health insurance coverage, shall
provide benefits under such plan or coverage (as applicable) for all
specified inhaler products and, with respect to such a product, may
not--
``
(1) apply any deductible; or
``
(2) impose any cost-sharing requirement in excess of $15
per 30-day supply of such product.
``
(b) Counting Cost-Sharing Towards Deductible and Out-of-Pocket
Maximum.--A group health plan, and a health insurance issuer offering
group or individual health insurance coverage, shall count any cost-
sharing requirement described in subsection
(a)
(2) incurred by a
participant, beneficiary, or enrollee of such plan or coverage with
respect to a specified inhaler product towards any out-of-pocket
maximum and any deductible that, but for application of subsection
(a) ,
would have applied to such participant, beneficiary, or enrollee with
respect to such product.
``
(c) Specified Inhaler Product Defined.--For purposes of this
section, the term `specified inhaler product' means any maintenance or
reliever or rescue inhalation drug (including inhalation aerosols,
metered dose inhalers, dry powder inhalers, inhalation solutions,
bronchodilators, and corticosteroids) with a medically accepted
indication (as defined in
``
(a) In General.--A group health plan, and a health insurance
issuer offering group or individual health insurance coverage, shall
provide benefits under such plan or coverage (as applicable) for all
specified inhaler products and, with respect to such a product, may
not--
``
(1) apply any deductible; or
``
(2) impose any cost-sharing requirement in excess of $15
per 30-day supply of such product.
``
(b) Counting Cost-Sharing Towards Deductible and Out-of-Pocket
Maximum.--A group health plan, and a health insurance issuer offering
group or individual health insurance coverage, shall count any cost-
sharing requirement described in subsection
(a)
(2) incurred by a
participant, beneficiary, or enrollee of such plan or coverage with
respect to a specified inhaler product towards any out-of-pocket
maximum and any deductible that, but for application of subsection
(a) ,
would have applied to such participant, beneficiary, or enrollee with
respect to such product.
``
(c) Specified Inhaler Product Defined.--For purposes of this
section, the term `specified inhaler product' means any maintenance or
reliever or rescue inhalation drug (including inhalation aerosols,
metered dose inhalers, dry powder inhalers, inhalation solutions,
bronchodilators, and corticosteroids) with a medically accepted
indication (as defined in
section 1927
(k)
(6) of the Social Security
Act) for the treatment for lung diseases such as asthma and chronic
obstructive pulmonary disease.
(k)
(6) of the Social Security
Act) for the treatment for lung diseases such as asthma and chronic
obstructive pulmonary disease. Such term includes any equipment used in
the administration of such drug (such as masks and tubing, spacers,
nebulizers, and valve-holding chambers).''.
(B) IRC.--
(i) In general.--Subchapter B of chapter
100 of the Internal Revenue Code of 1986 is
amended by adding at the end the following new
section:
``
SEC. 9826.
INHALER PRODUCTS.
``
(a) In General.--A group health plan shall provide benefits under
such plan for all specified inhaler products and, with respect to such
a product, may not--
``
(1) apply any deductible; or
``
(2) impose any cost-sharing requirement in excess of $15
per 30-day supply of such product.
``
(b) Counting Cost-Sharing Towards Deductible and Out-of-Pocket
Maximum.--A group health plan shall count any cost-sharing requirement
described in subsection
(a)
(2) incurred by a participant or beneficiary
of such plan with respect to a specified inhaler product towards any
out-of-pocket maximum and any deductible that, but for application of
subsection
(a) , would have applied to such participant or beneficiary
with respect to such product.
``
(c) Specified Inhaler Product Defined.--For purposes of this
section, the term `specified inhaler product' means any maintenance or
reliever or rescue inhalation drug (including inhalation aerosols,
metered dose inhalers, dry powder inhalers, inhalation solutions,
bronchodialators, and corticosteroids) with a medically accepted
indication (as defined in
``
(a) In General.--A group health plan shall provide benefits under
such plan for all specified inhaler products and, with respect to such
a product, may not--
``
(1) apply any deductible; or
``
(2) impose any cost-sharing requirement in excess of $15
per 30-day supply of such product.
``
(b) Counting Cost-Sharing Towards Deductible and Out-of-Pocket
Maximum.--A group health plan shall count any cost-sharing requirement
described in subsection
(a)
(2) incurred by a participant or beneficiary
of such plan with respect to a specified inhaler product towards any
out-of-pocket maximum and any deductible that, but for application of
subsection
(a) , would have applied to such participant or beneficiary
with respect to such product.
``
(c) Specified Inhaler Product Defined.--For purposes of this
section, the term `specified inhaler product' means any maintenance or
reliever or rescue inhalation drug (including inhalation aerosols,
metered dose inhalers, dry powder inhalers, inhalation solutions,
bronchodialators, and corticosteroids) with a medically accepted
indication (as defined in
section 1927
(k)
(6) of the Social Security Act
(42 U.
(k)
(6) of the Social Security Act
(42 U.S.C. 13964-8
(k)
(6) )) for the treatment of asthma or of chronic
obstructive pulmonary disease. Such term includes any equipment used in
the administration of such drug (such as masks and tubing, spacers,
nebulizers, and valve-holding chambers).''.
(ii) Clerical amendment.--The table of
sections for subchapter B of chapter 100 of the
Internal Revenue Code of 1986 is amended by
adding at the end the following new item:
``
Sec. 9826.
inhaler products.''.
(C) ERISA.--
(i) In general.--Subpart B of part 7 of
subtitle B of title I of the Employee
Retirement Income Security Act of 1974 is
amended by adding at the end the following new
section:
``
(C) ERISA.--
(i) In general.--Subpart B of part 7 of
subtitle B of title I of the Employee
Retirement Income Security Act of 1974 is
amended by adding at the end the following new
section:
``
SEC. 726.
INHALER PRODUCTS.
``
(a) In General.--A group health plan, and a health insurance
issuer offering group health insurance coverage, shall provide benefits
under such plan or coverage (as applicable) for all specified inhaler
products and, with respect to such a product, may not--
``
(1) apply any deductible; or
``
(2) impose any cost-sharing requirement in excess of $15
per 30-day supply of such product.
``
(b) Counting Cost-Sharing Towards Deductible and Out-of-Pocket
Maximum.--A group health plan, and a health insurance issuer offering
group health insurance coverage, shall count any cost-sharing
requirement described in subsection
(a)
(2) incurred by a participant or
beneficiary of such plan with respect to a specified inhaler product
towards any out-of-pocket maximum and any deductible that, but for
application of subsection
(a) , would have applied to such participant
or beneficiary with respect to such product.
``
(c) Specified Inhaler Product Defined.--For purposes of this
section, the term `specified inhaler product' means any maintenance or
reliever or rescue inhalation drug (including inhalation aerosols,
metered dose inhalers, dry powder inhalers, inhalation solutions,
bronchodialators, and corticosteroids) with a medically accepted
indication (as defined in
``
(a) In General.--A group health plan, and a health insurance
issuer offering group health insurance coverage, shall provide benefits
under such plan or coverage (as applicable) for all specified inhaler
products and, with respect to such a product, may not--
``
(1) apply any deductible; or
``
(2) impose any cost-sharing requirement in excess of $15
per 30-day supply of such product.
``
(b) Counting Cost-Sharing Towards Deductible and Out-of-Pocket
Maximum.--A group health plan, and a health insurance issuer offering
group health insurance coverage, shall count any cost-sharing
requirement described in subsection
(a)
(2) incurred by a participant or
beneficiary of such plan with respect to a specified inhaler product
towards any out-of-pocket maximum and any deductible that, but for
application of subsection
(a) , would have applied to such participant
or beneficiary with respect to such product.
``
(c) Specified Inhaler Product Defined.--For purposes of this
section, the term `specified inhaler product' means any maintenance or
reliever or rescue inhalation drug (including inhalation aerosols,
metered dose inhalers, dry powder inhalers, inhalation solutions,
bronchodialators, and corticosteroids) with a medically accepted
indication (as defined in
section 1927
(k)
(6) of the Social Security Act
(42 U.
(k)
(6) of the Social Security Act
(42 U.S.C. 13964-8
(k)
(6) )) for the treatment of asthma or of chronic
obstructive pulmonary disease. Such term includes any equipment used in
the administration of such drug (such as masks and tubing, spacers,
nebulizers, and valve-holding chambers).''.
(ii) Clerical amendment.--The table of
contents in
section 1 of the Employee
Retirement Income Security Act of 1974 (29
U.
Retirement Income Security Act of 1974 (29
U.S.C. 1001 note) is amended by inserting after
the item relating to
U.S.C. 1001 note) is amended by inserting after
the item relating to
section 725 the following
new item:
``
new item:
``
``
Sec. 726.
inhaler products.''.
(D) Conforming amendments.--
(i) HDHP safe harbor.--
(D) Conforming amendments.--
(i) HDHP safe harbor.--
Section 223
(c) (2) of
the Internal Revenue Code of 1986 is amended by
adding at the end the following new
subparagraph:
``
(I) Safe harbor for absence of deductible for
specified inhaler products.
(c) (2) of
the Internal Revenue Code of 1986 is amended by
adding at the end the following new
subparagraph:
``
(I) Safe harbor for absence of deductible for
specified inhaler products.--For plan years beginning
on or after January 1, 2026, a plan shall not fail to
be treated as a high deductible health plan by reason
of failing to have a deductible for specified inhaler
products (as defined in
the Internal Revenue Code of 1986 is amended by
adding at the end the following new
subparagraph:
``
(I) Safe harbor for absence of deductible for
specified inhaler products.--For plan years beginning
on or after January 1, 2026, a plan shall not fail to
be treated as a high deductible health plan by reason
of failing to have a deductible for specified inhaler
products (as defined in
section 2799A-11 of the Public
Health Service Act).
Health Service Act).''.
(ii) Catastrophic plan safe harbor.--
(ii) Catastrophic plan safe harbor.--
Section 1302
(e)
(1)
(B)
(i) of the Patient
Protection and Affordable Care Act (42 U.
(e)
(1)
(B)
(i) of the Patient
Protection and Affordable Care Act (42 U.S.C.
18022
(e)
(1)
(B)
(i) ) is amended by inserting ``or
2799A-11 of the Public Health Service Act''
after ``
section 2713''.
(E) Effective date.--The amendments made by this
paragraph shall apply to plan years beginning on or
after January 1, 2026.
(2) Medicare.--
(A) Part b.--
paragraph shall apply to plan years beginning on or
after January 1, 2026.
(2) Medicare.--
(A) Part b.--
Section 1833 of the Social Security
Act (42 U.
Act (42 U.S.C. 1395l) is amended--
(i) in subsection
(a)
(1)
(S) --
(I) in clause
(i) , by inserting
``or
(iii) '' after ``clause
(ii) ''; and
(II) by adding at the end the
following new clause: ``and
(iii) with
respect to a specified inhaler product
(as defined in
(i) in subsection
(a)
(1)
(S) --
(I) in clause
(i) , by inserting
``or
(iii) '' after ``clause
(ii) ''; and
(II) by adding at the end the
following new clause: ``and
(iii) with
respect to a specified inhaler product
(as defined in
section 2799A-11 of the
Public Health Service Act) furnished on
or after January 1, 2026, the amounts
paid shall be 100 percent of the lesser
of the actual charge or the payment
amount established in
Public Health Service Act) furnished on
or after January 1, 2026, the amounts
paid shall be 100 percent of the lesser
of the actual charge or the payment
amount established in
or after January 1, 2026, the amounts
paid shall be 100 percent of the lesser
of the actual charge or the payment
amount established in
section 1842
(o) (or, if applicable, under
(o) (or, if applicable, under
section 1847,
1847A, or 1847B), less, per 30-day
supply of such product, $15,''; and
(ii) in subsection
(b) , in the first
sentence--
(I) in paragraph
(12) , by striking
``, and''; and
(II) by striking ``.
1847A, or 1847B), less, per 30-day
supply of such product, $15,''; and
(ii) in subsection
(b) , in the first
sentence--
(I) in paragraph
(12) , by striking
``, and''; and
(II) by striking ``..'' and
inserting ``, and
(14) such deductible
shall not apply with respect to a
specified inhaler product (as defined
in
supply of such product, $15,''; and
(ii) in subsection
(b) , in the first
sentence--
(I) in paragraph
(12) , by striking
``, and''; and
(II) by striking ``..'' and
inserting ``, and
(14) such deductible
shall not apply with respect to a
specified inhaler product (as defined
in
section 2799A-11 of the Public
Health Service Act) furnished on or
after January 1, 2026.
Health Service Act) furnished on or
after January 1, 2026.''.
(B) Part d.--
(i) In general.--
after January 1, 2026.''.
(B) Part d.--
(i) In general.--
Section 1860D-2
(b) of the
Social Security Act (42 U.
(b) of the
Social Security Act (42 U.S.C. 1395w-102
(b) ) is
amended--
(I) in paragraph
(1)
(A) , by
striking ``paragraphs
(8) and
(9) '' and
inserting ``paragraphs
(8) ,
(9) , and
(10) '';
(II) in paragraph
(2)
(A) , by
striking ``paragraphs
(8) and
(9) '' and
inserting ``paragraphs
(8) ,
(9) , and
(10) '';
(III) in paragraph
(4)
(A)
(i) , by
striking ``paragraphs
(8) and
(9) '' and
inserting ``paragraphs
(8) ,
(9) , and
(10) ''; and
(IV) by adding at the end the
following new paragraph:
``
(10) Treatment of cost-sharing for specified inhaler
products.--
``
(A) No application of deductible.--For plan year
2026 and subsequent plan years, the deductible under
paragraph
(1) shall not apply with respect to any
specified inhaler product.
``
(B) Application of cost-sharing.--For plan year
2026 and subsequent plan years, the coverage provides
benefits for any specified inhaler product with cost-
sharing for a month's supply that does not exceed $15.
``
(C) === Definition. ===
-For purposes of this paragraph,
the term `specified inhaler product' has the meaning
given such term in
section 2799A-11 of the Public
Health Service Act.
Health Service Act.''.
(ii) Conforming amendment for alternative
prescription drug coverage.--
(ii) Conforming amendment for alternative
prescription drug coverage.--
Section 1860D-2
(c) of the Social Security Act (42 U.
(c) of the Social Security Act (42 U.S.C. 1395w-
102
(c) ) is amended by adding at the end the
following new paragraph:
``
(7) Treatment of cost-sharing for specified insulin
products.--The coverage in provided in accordance with
subsection
(b)
(10) .''.
(iii) Conforming amendments to cost-sharing
for low-income individuals.--
102
(c) ) is amended by adding at the end the
following new paragraph:
``
(7) Treatment of cost-sharing for specified insulin
products.--The coverage in provided in accordance with
subsection
(b)
(10) .''.
(iii) Conforming amendments to cost-sharing
for low-income individuals.--
Section 1860D-
14
(a)
(1) of the Social Security Act (42 U.
14
(a)
(1) of the Social Security Act (42 U.S.C.
1395w-114
(a)
(1) ) is amended--
(I) in subparagraph
(D)
(iii) , by
adding at the end the following new
sentence: ``For plan year 2026 and
subsequent plan years, the copayment
amount applicable under the preceding
sentence to a month's supply of a
specified inhaler product (as defined
in
(a)
(1) of the Social Security Act (42 U.S.C.
1395w-114
(a)
(1) ) is amended--
(I) in subparagraph
(D)
(iii) , by
adding at the end the following new
sentence: ``For plan year 2026 and
subsequent plan years, the copayment
amount applicable under the preceding
sentence to a month's supply of a
specified inhaler product (as defined
in
section 1860D-2
(b)
(10) ) dispensed to
the individual may not exceed $15.
(b)
(10) ) dispensed to
the individual may not exceed $15.'';
and
(II) in subparagraph
(E) , by
inserting ``or under
section 1860D-
2
(b)
(10) in the case of a specified
inhaler product (as defined in such
section)'' after ``(as defined in
subparagraph
(C) of such section)''.
2
(b)
(10) in the case of a specified
inhaler product (as defined in such
section)'' after ``(as defined in
subparagraph
(C) of such section)''.
(b) Payment Program for Uninsured Individuals.--Part P of title III
of the Public Health Service Act (42 U.S.C. 280g et seq.) is amended by
adding at the end the following new section:
``
(b)
(10) in the case of a specified
inhaler product (as defined in such
section)'' after ``(as defined in
subparagraph
(C) of such section)''.
(b) Payment Program for Uninsured Individuals.--Part P of title III
of the Public Health Service Act (42 U.S.C. 280g et seq.) is amended by
adding at the end the following new section:
``
SEC. 399V-8.
``
(a) In General.--Beginning January 1, 2026, the Secretary shall
establish a program under which--
``
(1) program-registered providers submit claims to the
Secretary with respect to the furnishing of specified inhaler
products (as defined in subsection
(b) ) to uninsured
individuals; and
``
(2) the Secretary, subject to the availability of
appropriations, pays each such provider for such products in an
amount determined appropriate by the Secretary.
``
(b)
=== Definitions. ===
-In this section:
``
(1) Program-registered provider.--The term `program-
registered provider' means a health care provider that--
``
(A) is licensed or otherwise authorized to
administer or dispense specified inhaler products in
the State in which such provider so administers or
dispenses such products under the program established
under this section; and
``
(B) enters into an agreement with the Secretary
under which the provider agrees not to hold an
uninsured individual liable for the cost of any such
product administered or dispensed to such individual in
an amount exceeding $15 for a month's supply of such
product if a payment is made under subsection
(a)
(2) with respect to such product so administered or
dispensed.
``
(2) Specified inhaler product.--The term `specified
inhaler product' has the meaning given such term in
section 2799A-11.
``
(3) Uninsured individual.--The term `uninsured
individual' means, with respect to an individual furnished a
specified inhaler product, an individual who is not enrolled
in--
``
(A) a Federal health care program (as defined in
(3) Uninsured individual.--The term `uninsured
individual' means, with respect to an individual furnished a
specified inhaler product, an individual who is not enrolled
in--
``
(A) a Federal health care program (as defined in
section 1128B
(f) of the Social Security Act);
``
(B) a group health plan or health insurance
coverage offered by a health insurance issuer in the
group or individual market (as such terms are defined
in
(f) of the Social Security Act);
``
(B) a group health plan or health insurance
coverage offered by a health insurance issuer in the
group or individual market (as such terms are defined
in
section 2791); or
``
(C) a health plan offered under chapter 89 of
title 5, United States Code.
``
(C) a health plan offered under chapter 89 of
title 5, United States Code.''.
(c) Implementation.--The Secretary of Health and Human Services may
implement the amendments made by this section by program instruction,
subregulatory guidance, or otherwise.
<all>
(C) a health plan offered under chapter 89 of
title 5, United States Code.''.
(c) Implementation.--The Secretary of Health and Human Services may
implement the amendments made by this section by program instruction,
subregulatory guidance, or otherwise.
<all>